Dr. Mark Flyer

IS
CTRM: Changing how radiologists and clinicians communicate
The adoption of critical test results management (CTRM) software can bring changes in how radiologists communicate with referring physicians -- changes for the better. In this article, Dr. Mark Flyer of Maimonides Medical Center describes how his hospital's implementation of a CTRM system led to better communication.
August 11, 2013
2013 08 09 14 12 04 690 Flyer Mark 200
Page 1 of 1
Top Stories
Keeping Up With The Radiologists Podcast Thumbnail
Podcast Network
Podcast: Frank Lexa discusses the 3 major trends facing radiology today
Can radiology stay human in an era of mega-practices, private equity, and AI?
Woman Mother Stressed 400
MRI
MRI shows how hormones affect mood
Radiologists
Practice Management
Radiologist pipeline trails increase in training positions
Mammo Adobe Gorodenkoff
Breast
Neighborhood deprivation tied to lower breast cancer screening
Shutterstock 2028051956 (1)
Molecular Imaging
SPECT/CT access unequal across U.S.
More in Home
Podcast: Frank Lexa discusses the 3 major trends facing radiology today
By Liz Carey
Can radiology stay human in an era of mega-practices, private equity, and AI?
September 3, 2026
Keeping Up With The Radiologists Podcast Thumbnail
MRI shows how hormones affect mood
By Amerigo Allegretto
MRI scans show how higher progesterone levels indicate lower mood.
September 2, 2026
Woman Mother Stressed 400
Radiologist pipeline trails increase in training positions
By Will Morton
Radiology residency positions rose 33% between 2010 and 2025.
September 2, 2026
Radiologists
Neighborhood deprivation tied to lower breast cancer screening
By Amerigo Allegretto
Women residing in neighborhoods with high deprivation have lower odds of getting their mammograms.
September 2, 2026
Mammo Adobe Gorodenkoff
SPECT/CT access unequal across U.S.
By Will Morton
At the state level, California, Texas, and Florida had the highest number of facilities in absolute terms.
September 1, 2026
Shutterstock 2028051956 (1)
AI cuts chest CT reporting time
By Will Morton
Exploratory modeling suggested an approximate reduction of 0.5 full-time equivalent radiologist workload.
September 1, 2026
Example of AI-assisted pulmonary nodule detection and longitudinal volumetric assessment in a 65-year-old woman with peripheral arterial disease, a 24-pack-year smoking history, emphysema, and a family history of lung cancer. An incidental 8.5-mm right lower lobe pulmonary nodule is identified at CT angiography of the abdomen in July 2022 but does not receive follow-up. Subsequent imaging demonstrates interval growth, and CT-guided biopsy confirms stage IA lung adenocarcinoma. Contrast-enhanced axial chest CT images obtained on February 2, 2024, before robotic-assisted thoracoscopic segmentectomy, show a 12.1-mm spiculated right lower lobe pulmonary nodule. (A) Conventional contrast-enhanced axial chest CT image without AI assistance shows a 12.1-mm spiculated right lower lobe pulmonary nodule. (B) Corresponding CT image with AI-assisted pulmonary nodule detection, automated segmentation, and quantitative nodule assessment identifies a solid pulmonary nodule (nodule #1) measuring 13 × 8 (11) mm, with a volume of 739 mm3, a 45% volumetric increase compared with the previous contrast-enhanced chest CT performed on October 9, 2023 (510 mm3), and an estimated volume doubling time (VDT) of 216 days. (C) AI-generated longitudinal nodule analysis displays automated segmentation of the current (February 2, 2024) and previous (October 9, 2023) CT examinations, 3D nodule reconstruction, and quantitative volumetric assessment for longitudinal follow-up. The AI interface is displayed in the original software language (Dutch).
PCCT on par with MRI for diagnostic breast imaging
By Amerigo Allegretto
PCCT performed similarly to MRI for characterizing breast lesions and finding additional lesions.
September 1, 2026
Detection and extent of BI-RADS suspicious calcifications (amorphous, coarse heterogeneous, fine pleomorphic, and fine linear or fine linear branching) at axial photon-counting CT (PCCT) versus full-field digital mammography (first three images, craniocaudal view; last image, mediolateral oblique view). Calcifications found on mammography showed only partial visualization at ultrahigh-resolution PCCT (0.2 mm), while amorphous calcifications could not be distinguished from image noise. Corresponding abnormal enhancement was clearly depicted on contrast-enhanced PCCT images.
Self-interpreting by ordering clinicians tied to low-value imaging
By Amerigo Allegretto
Visits involving clinicians who self-interpreted all their ordered imaging had higher odds of imaging overall.
September 1, 2026
Radiological Report 400
POCUS improves timeliness in emergency pregnancy care
By Amerigo Allegretto
Emergency POCUS can reduce length of stay and time to diagnosis while not leading to more missed diagnoses of ectopic pregnancy.
August 31, 2026
Ultrasound Portable 400
Bayer's PET agent meets endpoints in phase III cardiac amyloidosis study
By Will Morton
Overall sensitivity was 94% (95% CI, 85% to 98%) and specificity was 86% (95% CI, 77% to 92%).
August 31, 2026
This figure shows fused I-124 evuzamitide positron emission tomography (PET)/computed tomography (CT) images from patients without amyloidosis and from patients with ATTR cardiac amyloidosis, early ATTR cardiac amyloidosis, light chain cardiac amyloidosis, gelsolin-mediated amyloidosis, and systemic organ amyloid. The columns represent radiological transaxial, sagittal, and coronal views except for the last row middle and far right columns, which are coronal projections. The blue asterisks represent physiological activity (tracer activity in the stomach and esophagus). The arrowheads represent pathological uptake. Note the small amount of cardiac uptake in the basal septum and the basal lateral walls (likely early ATTR cardiac amyloidosis), splenic uptake and pleural uptake in light chain amyloidosis, and cardiac and kidney uptake in gelsolin-mediated amyloidosis. The bright yellow color represents more tracer uptake.
MRI-based biomarker tool can predict progression to dementia
By Amerigo Allegretto
The tool measures gray matter shrinkage in the brain, predicting when mild cognitive impairment progresses to dementia.
August 28, 2026
Brain 400
Is nitroglycerin necessary prior to photon-counting CT?
By Will Morton
Sublingual nitroglycerin is routinely administered before CCTA to induce coronary vasodilation.
August 27, 2026
Representative case from the non-nitroglycerin cohort. A 92-year-old man who did not receive sublingual nitroglycerin because of severe aortic stenosis. The Agatston coronary artery calcium score was 5438. (A) Curved multiplanar reformatted CCTA image reconstructed at 0.4-mm slice thickness using a Bv60 kernel and QIR strength 3 demonstrates diffuse multifocal mild luminal stenoses related to extensive calcified atherosclerotic plaque. (B) Invasive coronary angiography confirmed multifocal mild stenoses without evidence of obstructive coronary artery disease.
Page 1 of 248
Next Page